focusIR May 2024 Investor Webinar: Blue Whale, Kavango, Taseko Mines & CQS Natural Resources. Catch up with the webinar here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksQinetiq Regulatory News (QQ.)

Share Price Information for Qinetiq (QQ.)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 369.20
Bid: 369.00
Ask: 369.60
Change: 1.80 (0.49%)
Spread: 0.60 (0.163%)
Open: 360.20
High: 369.20
Low: 360.20
Prev. Close: 367.40
QQ. Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Pre-Close Trading Statement

29 Sep 2017 07:00

RNS Number : 1742S
QinetiQ Group plc
29 September 2017
 

News release

 

QinetiQ Group plc

Pre Close Trading Update

29 September 2017

QinetiQ today issues a short trading update before entering its closed period for the half year ending 30 September 2017.

Outlook

Trading has been in line with expectations and the outlook for overall Group performance this financial year is unchanged.

EMEA Services

The EMEA Services division started the year in a strong position. Following stronger order intake in the second quarter, FY18 revenue under contract is as expected at this stage in the financial year. We reiterate our guidance for modest growth in revenue in FY18.

Global Products

The Group's Global Products division has been trading in line with expectations during the first half of the year. As a result of its contracted orders and pipeline of opportunities, as well as the anticipated full year contribution from QinetiQ Target Systems, the division is expected to grow in FY18.

Strategic progress

QinetiQ continues to make progress towards becoming a more customer focused and international company. In both the UK and internationally we are particularly well placed to help customers meet the challenges of increasing capabilities while addressing budgetary concerns, and this is reflected in recent key contract awards.

In our UK home market, as part of our strategy to modernise test and evaluation, we secured:

·

An £8m order from the UK Ministry of Defence (MOD) to provide naval combat systems expertise for Type 26 Global Combat Ship added to the £110m 11-year Naval Combat System Integration Support Services (NCSISS) contract agreed with the MOD this time last year

·

An order from Boeing, worth approximately £25m, to continue to deliver wind tunnel testing for their commercial aircraft development until 2024

 

In our US and Australian home markets, as part of our strategy to build an international company, we were awarded:

 

·

A significant order for aircraft launch and recovery equipment for the new class of US Navy aircraft carriers

·

An AU$8m order to manage mine warfare maintenance facilities at HMAS Waterhen for the Australian Department of Defence

 

 

ENDS

 

 

Notes for Editors:

 

For further information please contact:

 

David Bishop, Group Director Investor Relations and Communications

+44 (0) 7920 108675

Investor Relations

Ian Brown, Group Head of Investor Relations

+44 (0) 7908 251123

Media Relations

QinetiQ press office

+44 (0) 1252 393500

 

QinetiQ's interim results for the half year ending 30 September 2017 will be announced on 16 November 2017.

 

Listed on the London Stock Exchange (LSE: QQ.L), QinetiQ is a leading science and engineering company operating primarily in the defence, security and aerospace markets. Our customers are predominantly government organisations including defence departments, as well as international customers in other targeted sectors.

 

·

Visit our website www.QinetiQ.com

·

Follow us on LinkedIn and Twitter @QinetiQ

·

Visit our blog www.QinetiQ-blogs.com

 

 

 

Disclaimer

 

This document contains certain forward-looking statements relating to the business, strategy, financial performance and results of the Company and/or the industry in which it operates. Actual results, levels of activity, performance, achievements and events are most likely to vary materially from those implied by the forward-looking statements. The forward-looking statements concern future circumstances and results and other statements that are not historical facts, sometimes identified by the words 'believes',' expects', 'predicts', 'intends', 'projects', 'plans', 'estimates', 'aims', 'foresees', 'anticipates', 'targets', 'goals', 'due', 'could', 'may', 'should', 'potential', 'likely' and similar expressions, although these words are not the exclusive means of doing so. These forward-looking statements include, without limitation, statements regarding the Company's future financial position, income growth, impairment charges, business strategy, projected levels of growth in the relevant markets, projected costs, estimates of capital expenditures, and plans and objectives for future operations. Forward-looking statements contained in this announcement regarding past trends or activities should not be taken as a representation that such trends or activities will continue in the future. Nothing in this document should be regarded as a profit forecast.

The forward-looking statements, including assumptions, opinions and views of the Company or cited from third party sources, contained in this announcement are solely opinions and forecasts which are uncertain and subject to risks. Although the Company believes that the expectations reflected in these forward-looking statements are reasonable, it can give no assurance that these expectations will prove to be correct. Actual results may differ materially from those expressed or implied by these forward-looking statements. A number of factors could cause actual events to differ significantly and these are set out in the principal risks and uncertainties section of this document. Most of these factors are difficult to predict accurately and are generally beyond the control of the Company. Any forward-looking statements made by, or on behalf of, the Company speak only as of the date they are made. Save as required by law, the Company will not publicly release the results of any revisions to any forward-looking statements in this document that may occur due to any change in the Directors' expectations or to reflect events or circumstances after the date of this document.

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
TSTLFFVLAFITFID
Date   Source Headline
27th Apr 20227:00 amRNSInvestor Seminar: Delivering our global ambition
26th Apr 20221:37 pmRNSHolding(s) in Company
21st Apr 20229:15 amRNSHolding(s) in Company
20th Apr 20227:00 amRNSFourth Quarter Trading Update
12th Apr 202212:45 pmRNSDirector/PDMR Shareholding
10th Mar 202211:27 amRNSDirector/PDMR Shareholding
10th Feb 202211:52 amRNSDirector/PDMR Shareholding
10th Feb 202211:52 amRNSDirector/PDMR Shareholding
2nd Feb 20228:42 amRNSHolding(s) in Company
24th Jan 202211:12 amRNSDirector/PDMR Shareholding
19th Jan 20221:43 pmRNSHolding(s) in Company
18th Jan 20227:00 amRNSThird Quarter Trading Update
17th Jan 20227:00 amRNSAppointment of President and CEO of QinetiQ US
11th Jan 202211:43 amRNSDirector/PDMR Shareholding
5th Jan 20225:05 pmRNSDirector/PDMR Shareholding
20th Dec 20219:21 amRNSDirector Declaration
10th Dec 202112:42 pmRNSDirector/PDMR Shareholding
6th Dec 202112:16 pmRNSHolding(s) in Company
18th Nov 202111:04 amRNSDirector/PDMR Shareholding
17th Nov 202110:54 amRNSDirector/PDMR Shareholding
16th Nov 202111:24 amRNSDirector/PDMR Shareholding
11th Nov 20217:00 amRNSInterim Results
10th Nov 202112:12 pmRNSDirector/PDMR Shareholding
1st Nov 202111:43 amRNSBlock listing Interim Review
19th Oct 20219:16 amRNSHolding(s) in Company
14th Oct 20217:00 amRNSTrading Update
12th Oct 202110:43 amRNSDirector/PDMR Shareholding
10th Sep 20212:07 pmRNSDirector/PDMR Shareholding
31st Aug 20212:35 pmRNSDirector/PDMR Shareholding
11th Aug 20219:07 amRNSDirector/PDMR Shareholding
27th Jul 202110:46 amRNSDirectorate Change
26th Jul 20214:33 pmRNSDirector/PDMR Shareholding
21st Jul 202110:55 amRNSResult of AGM
21st Jul 20217:00 amRNSFirst Quarter Trading Update
14th Jul 20218:47 amRNSChange of AGM venue
13th Jul 20219:52 amRNSHolding(s) in Company
12th Jul 202111:12 amRNSDirector/PDMR Shareholding
2nd Jul 20217:00 amRNSChief Financial Officer succession
29th Jun 20213:49 pmRNSDirector/PDMR Shareholding
15th Jun 202110:55 amRNSAnnual Financial Report
10th Jun 202111:15 amRNSDirector/PDMR Shareholding
9th Jun 20215:01 pmRNSDirector/PDMR Shareholding
1st Jun 20219:34 amRNSTotal Voting Rights
25th May 202110:54 amRNSBlock Listing Application
20th May 20217:00 amRNSPreliminary Results
11th May 20211:53 pmRNSDirector/PDMR Shareholding
27th Apr 20212:08 pmRNSDeath of Non-Executive Director, Ian Mason
15th Apr 20212:49 pmRNSHolding(s) in Company
14th Apr 20217:00 amRNSTrading Update
12th Apr 20212:00 pmRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.